Image pharmaphorum Editor Digital NHS IT glitch ‘caused deaths by cancelling cancer screening’ Health secretary Jeremy Hunt to launch inquiry News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused. News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks News SMEs: the next generation of pharma The future beyond blockbusters: more precise, more patient-centred and more SME-led. Load more results
Digital NHS IT glitch ‘caused deaths by cancelling cancer screening’ Health secretary Jeremy Hunt to launch inquiry
News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused.
News AZ's Tagrisso looks set for first-line lung cancer label in ... Expanded label likely in coming weeks
News SMEs: the next generation of pharma The future beyond blockbusters: more precise, more patient-centred and more SME-led.
News Novo Nordisk beefs up in oral obesity drugs with Vivtex deal Novo Nordisk is leaving no stone unturned in its bid to maintain its position in weight-loss therapies as it signs a $2.1bn alliance with Vivtex.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
